Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.06 | 0.8 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |